said it would cut about 45 percent of its workforce after the
U.S. Food and Drug Administration denied approval of its
sleep-disorder drug...
feeds newissuesnews reuters newissuesnews feeds reuters hotstocksnews hotstocknews feeds hotstocknews
feeds newissuesnews reuters newissuesnews feeds reuters hotstocksnews hotstocknews feeds hotstocknews
No comments:
Post a Comment